These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 12191966

  • 1. PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.
    Cernuda-Morollón E, Rodríguez-Pascual F, Klatt P, Lamas S, Pérez-Sala D.
    J Am Soc Nephrol; 2002 Sep; 13(9):2223-31. PubMed ID: 12191966
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB.
    Gómez-Guerrero C, López-Franco O, Suzuki Y, Sanjuán G, Hernández-Vargas P, Blanco J, Egido J.
    Kidney Int; 2002 Dec; 62(6):2022-34. PubMed ID: 12427126
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability.
    Eberhardt W, Akool el-S, Rebhan J, Frank S, Beck KF, Franzen R, Hamada FM, Pfeilschifter J.
    J Biol Chem; 2002 Sep 06; 277(36):33518-28. PubMed ID: 12093797
    [Abstract] [Full Text] [Related]

  • 6. Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.
    Kim EJ, Kwon KJ, Park JY, Lee SH, Moon CH, Baik EJ.
    Brain Res; 2002 Jun 21; 941(1-2):1-10. PubMed ID: 12031542
    [Abstract] [Full Text] [Related]

  • 7. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells.
    Datta PK, Lianos EA.
    Kidney Int; 1999 Aug 21; 56(2):486-93. PubMed ID: 10432387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K, Shichiri M, Marumo F, Hirata Y.
    Arterioscler Thromb Vasc Biol; 1998 Nov 21; 18(11):1796-802. PubMed ID: 9812920
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
    Eberhardt W, Plüss C, Hummel R, Pfeilschifter J.
    J Immunol; 1998 May 15; 160(10):4961-9. PubMed ID: 9590244
    [Abstract] [Full Text] [Related]

  • 12. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
    Chang PC, Chen TH, Chang CJ, Hou CC, Chan P, Lee HM.
    Kidney Int; 2004 May 15; 65(5):1664-75. PubMed ID: 15086905
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-kappaB in primary astrocytes.
    Pahan K, Liu X, McKinney MJ, Wood C, Sheikh FG, Raymond JR.
    J Neurochem; 2000 Jun 15; 74(6):2288-95. PubMed ID: 10820188
    [Abstract] [Full Text] [Related]

  • 15. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.
    Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, Nawata H.
    Hepatology; 2001 Jan 15; 33(1):91-9. PubMed ID: 11124825
    [Abstract] [Full Text] [Related]

  • 16. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
    Katsuyama K, Shichiri M, Kato H, Imai T, Marumo F, Hirata Y.
    Endocrinology; 1999 May 15; 140(5):2183-90. PubMed ID: 10218970
    [Abstract] [Full Text] [Related]

  • 17. Cycloprodigiosin up-regulates inducible nitric oxide synthase gene expression in hepatocytes stimulated by interleukin-1beta.
    Teshima S, Nakanishi H, Kamata K, Kaibori M, Kwon AH, Kamiyama Y, Nishizawa M, Ito S, Okumura T.
    Nitric Oxide; 2004 Aug 15; 11(1):9-16. PubMed ID: 15350552
    [Abstract] [Full Text] [Related]

  • 18. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
    Paukkeri EL, Leppänen T, Sareila O, Vuolteenaho K, Kankaanranta H, Moilanen E.
    Br J Pharmacol; 2007 Dec 15; 152(7):1081-91. PubMed ID: 17891158
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation of nitric oxide synthase mRNA expression by lipopolysaccharide and pro-inflammatory cytokines in fetal hepatocytes treated with cycloheximide.
    Casado M, Díaz-Guerra MJ, Boscá L, Martín-Sanz P.
    Biochem J; 1997 Nov 01; 327 ( Pt 3)(Pt 3):819-23. PubMed ID: 9581561
    [Abstract] [Full Text] [Related]

  • 20. cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured rat hepatocytes.
    Harbrecht BG, Taylor BS, Xu Z, Ramalakshmi S, Ganster RW, Geller DA.
    J Surg Res; 2001 Aug 01; 99(2):258-64. PubMed ID: 11469895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.